Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer

被引：0
|
作者：
Toshihiko Kaneda
Hiroshige Yoshioka
Motohiro Tamiya
Akihiro Tamiya
Akito Hata
Asukaka Okada
Takashi Niwa
Takayuki Shiroyama
Masaki Kanazu
Tadashi Ishida
Nobuyuki Katakami
机构：
[1] Kurashiki Central Hospital,Department of Respiratory Medicine
[2] Osaka Prefectural Medical Center for Respiratory and Allergic Diseases,Department of Thoracic Malignancy
[3] National Hospital Organization Kinki-chuo Chest Medical Center,Department of Internal Medicine
[4] Institute of Biomedical Research and Innovation,Division of Integrated Oncology
[5] Saiseikai Suita Hospital,Department of Respiratory Medicine
来源：
BMC Cancer | / 18卷
关键词：
Exon 19 deletion; L858R point mutation in exon 21; Non-squamous non-small cell lung cancer; Pemetrexed; Progression-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer
    Kaneda, T.
    Yoshioka, H.
    Tamiya, M.
    Tamiya, A.
    Hata, A.
    Okada, A.
    Niwa, T.
    Shiroyama, T.
    Kanazu, M.
    Ishida, T.
    Katakami, N.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [2] Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer
    Kaneda, Toshihiko
    Yoshioka, Hiroshige
    Tamiya, Motohiro
    Tamiya, Akihiro
    Hata, Akito
    Okada, Asukaka
    Niwa, Takashi
    Shiroyama, Takayuki
    Kanazu, Masaki
    Ishida, Tadashi
    Katakami, Nobuyuki
    [J]. BMC CANCER, 2018, 18
  • [3] PHARMACOGENETIC STUDY OF JAPANESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER TREATED WITH PEMETREXED PLUS CISPLATIN
    Imai, Hisao
    Takahashi, Toshiaki
    Serizawa, Masakuni
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Nakamura, Yukiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Koh, Yasuhiro
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1077 - S1077
  • [4] Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan
    Asami, Kazuhiro
    Kawahara, Masaaki
    Hirashima, Tomonori
    Suzuki, Hidekazu
    Okishio, Kyoichi
    Omachi, Naoki
    Tamiya, Motohiro
    Tamiya, Akihiro
    Hirooka, Aya
    Nakao, Keiko
    Tsuji, Taisuke
    Atagi, Shinji
    [J]. THORACIC CANCER, 2014, 5 (04) : 289 - 296
  • [5] Survival difference between EGFR Del19 and L858R mutant advanced non-small cell lung cancer patients receiving gefitinib: a propensity score matching analysis
    Zhuo, Minglei
    Zheng, Qiwen
    Zhao, Jun
    Wu, Meina
    An, Tongtong
    Wang, Yuyan
    Li, Jianjie
    Wang, Shuhang
    Zhong, Jia
    Yang, Xue
    Chen, Hanxiao
    Jia, Bo
    Dong, Zhi
    Gao, Emei
    Wang, Jingjing
    Wang, Ziping
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (06) : 553 - +
  • [6] Survival difference between EGFR Del19 and L858R mutant advanced non-small cell lung cancer patients receiving gefitinib:a propensity score matching analysis
    Minglei Zhuo
    Qiwen Zheng
    Jun Zhao
    Meina Wu
    Tongtong An
    Yuyan Wang
    Jianjie Li
    Shuhang Wang
    Jia Zhong
    Xue Yang
    Hanxiao Chen
    Bo Jia
    Zhi Dong
    Emei Gao
    Jingjing Wang
    Ziping Wang
    [J]. Chinese Journal of Cancer Research, 2017, 29 (06) : 553 - 560
  • [7] TOLERANCE AND EFFICACY OF PEMETREXED-CISPLATIN FOR ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER A GALICIAN LUNG CANCER GROUP STUDY
    Senin, Clara
    Campos, Begona
    Jose Villanueva, Maria
    Firvida, J. L.
    Baron, Francisco
    Amenedo, Margarita
    Afonso, Javier
    Lazaro, Martin
    Varela, S.
    Grande, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1277 - S1277
  • [8] Efficacy and Safety of Pemetrexed-Cisplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer - a Galician Lung Cancer Group Study
    Senin, C.
    Varela, S.
    Huidobro, G.
    Firvida, J. L.
    Baron, F.
    Amenedo, M.
    Afonso, F. J.
    Lazaro, M.
    Campos, B.
    Casal, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S624 - S624
  • [9] Effect of bevacizumab plus double dose icotinib on advanced non-small cell lung cancer with EGFR L858R mutation
    Jiang, Zhansheng
    Li, Yong
    Yan, Zhuchen
    Lan, Lan
    Zhang, Xinwei
    Ren, Baozhu
    Wang, Fei
    Zhang, Wencheng
    Pan, Zhanyu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
    Noor, Zorawar S.
    Goldman, Jonathan W.
    Lawler, William E.
    Telivala, Bijoy
    Braiteh, Fadi
    DiCarlo, Brian A.
    Kennedy, Kathleen
    Adams, Brad
    Wang, Xiaoyan
    Jones, Benjamin
    Slamon, Dennis J.
    Garon, Edward B.
    [J]. LUNG CANCER, 2019, 135 : 104 - 109
12345